What do you get out of GCMI’s Phase Zero?

Fast track answers to critical questions that de-risk medtech innovations   When an innovator has identified a medical problem, taking an efficient approach to minimize risk and identify the viability of potential solutions is key. Our Phase Zero focuses on evaluating critical product elements early, minimizing risk, cost and effort.    Key questions: What is…